SCHEMBL6660144

SCHEMBL6660144

CC1(C)CNCCc2cc(Cl)c(Cl)cc21

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 13/20 0.68
HTR2C P28335 13/20 0.68
HTR2B P41595 11/20 0.45
PNMT P11086 4/20 0.40
KDM1A O60341 2/20 0.38
ADRA2A P08913 2/20 0.36
ADRA2B P18089 2/20 0.36
ADRA2C P18825 2/20 0.36
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
ADRB1 P08588 1/20 0.36
HTR1A P08908 1/20 0.36
CNR1 P21554 1/20 0.36
HRH1 P35367 1/20 0.36
KCNH2 Q12809 1/20 0.36
SLC6A3 Q01959 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2368756 0.81 HTR2A (1.00) HTR2AHTR2CHTR2BPNMTKDM1A
SCHEMBL29051751 0.76 HTR2A (0.59) HTR2AHTR2C
SCHEMBL6661043 0.74 HTR2A (0.66) HTR2AHTR2CHTR2BPNMTKDM1A
SCHEMBL9058489 0.70 HTR2A (0.62) HTR2AHTR2CHTR2BPNMTKDM1A
SCHEMBL29051650 0.70 HTR2C (0.53) HTR2AHTR2CHTR2BKDM1AADRA2A
SCHEMBL5678916 0.69 HTR2C (0.51) HTR2AHTR2CHTR2BPNMTKDM1A
SCHEMBL184089 0.66 PNMT (0.61) HTR2AHTR2CHTR2BPNMTADRA2A
SCHEMBL9377934 0.66 HTR2C (0.38) HTR2AHTR2CHTR2B
SCHEMBL6298572 0.66 HTR2A (0.73) HTR2AHTR2CHTR2BPNMTKDM1A
SCHEMBL3757689 0.65 HTR2A (0.71) HTR2AHTR2CHTR2BPNMTKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411881-A4 5HT sb 2C /sb RECEPTOR MODULATORS ARENA PHARM INC (US) 2004-07-07 EP disclosed
EP-1411881-A2 5HT sb 2C /sb RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2004-04-28 EP disclosed
WO-2003086306-A2 5HT2C RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. (US) 2003-10-23 WO disclosed